Article
Burden of hereditary cancer susceptibility in unselected patients with pancreatic ductal adenocarcinoma referred for germline screening.
Cancer medicine - 1 Jun 2020
Cremin Carol, Lee Michael Kuan-Ching, Hong Quan, Hoeschen Carolyn, Mackenzie Anna, Dixon Katherine, McCullum Mary, Nuk Jennifer, Kalloger Steve, Karasinska Joanna, Scudamore Charles, Kim Peter T W, Donnellan Fergal, Lam Eric C S, Lim Howard J, Neben Cynthia L, Stedden Will, Zhou Alicia Y, Schaeffer David F, Sun Sophie, Renouf Daniel J, Schrader Kasmintan A
Abstract excerpt
BACKGROUND: Recent guidelines recommend consideration of germline testing for all newly diagnosed pancreatic ductal adenocarcinoma (PDAC). The primary aim of this study was to determine the burden of hereditary cancer susceptibility in PDAC. A secondary aim was to compare genetic testing uptake rates across different modes of genetic counselling. PATIENTS AND METHODS: All patients diagnosed with PDAC in the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
